Delivery Order SPE2DB25D3008-SPE2DB25FRBTA
Award Date
4/7/25
Potential Completion Date
4/28/25
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,466.57 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC enables the DLA to efficiently...
This is a $4,620.93 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through July 10, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,620.93 firm-fixed-price contract is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a specialty medication. The contract is not designated as a set-aside and appears to be part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. This IDC...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The award has a ceiling value of $13,862.79 and a final completion date of July 17, 2025. This delivery order is associated with Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,862.79 firm fixed-price contract is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication. The award is under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a $9,241.86 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ZEPOSIA 0.92 MG CAPSULE 30S. The contract has a period of performance through June 5, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the prescription medication ZEPOSIA 0.92 MG CAPSULE 30S. The contract is a firm-fixed price delivery order with a ceiling value of $4,466.57 and an ultimate completion date of October 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide the medication to support military treatment facilities and other government healthcare programs. This order is part...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication, with a ceiling value of $13,862.79 and a performance period ending on August 5, 2025. The contract is not set-aside and represents an open competition. AmerisourceBergen Drug Corporation holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ZEPOSIA 0.92 MG CAPSULE 30S. The contract has a ceiling value of $13,399.71 and an ultimate completion date of October 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,862.79 fixed-price delivery order is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a medication used in the treatment of various medical conditions. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...